Your browser doesn't support javascript.
loading
Distinctive Subpopulations of Stromal Cells Are Present in Human Lymph Nodes Infiltrated with Melanoma.
Eom, Jennifer; Park, Saem Mul; Feisst, Vaughan; Chen, Chun-Jen J; Mathy, Joanna E; McIntosh, Julie D; Angel, Catherine E; Bartlett, Adam; Martin, Richard; Mathy, Jon A; Cebon, Jonathan S; Black, Michael A; Brooks, Anna E S; Dunbar, P Rod.
Afiliación
  • Eom J; School of Biological Sciences, University of Auckland, Auckland, New Zealand.
  • Park SM; Maurice Wilkins Centre, University of Auckland, Auckland, New Zealand.
  • Feisst V; School of Biological Sciences, University of Auckland, Auckland, New Zealand.
  • Chen CJ; Maurice Wilkins Centre, University of Auckland, Auckland, New Zealand.
  • Mathy JE; School of Biological Sciences, University of Auckland, Auckland, New Zealand.
  • McIntosh JD; Maurice Wilkins Centre, University of Auckland, Auckland, New Zealand.
  • Angel CE; School of Biological Sciences, University of Auckland, Auckland, New Zealand.
  • Bartlett A; Maurice Wilkins Centre, University of Auckland, Auckland, New Zealand.
  • Martin R; School of Biological Sciences, University of Auckland, Auckland, New Zealand.
  • Mathy JA; Maurice Wilkins Centre, University of Auckland, Auckland, New Zealand.
  • Cebon JS; School of Biological Sciences, University of Auckland, Auckland, New Zealand.
  • Black MA; Maurice Wilkins Centre, University of Auckland, Auckland, New Zealand.
  • Brooks AES; School of Biological Sciences, University of Auckland, Auckland, New Zealand.
  • Dunbar PR; Maurice Wilkins Centre, University of Auckland, Auckland, New Zealand.
Cancer Immunol Res ; 8(8): 990-1003, 2020 08.
Article en En | MEDLINE | ID: mdl-32580941
ABSTRACT
Metastasis of human tumors to lymph nodes (LN) is a universally negative prognostic factor. LN stromal cells (SC) play a crucial role in enabling T-cell responses, and because tumor metastases modulate their structure and function, this interaction may suppress immune responses to tumor antigens. The SC subpopulations that respond to infiltration of malignant cells into human LNs have not been defined. Here, we identify distinctive subpopulations of CD90+ SCs present in melanoma-infiltrated LNs and compare them with their counterparts in normal LNs. The first population (CD90+ podoplanin+ CD105+ CD146+ CD271+ VCAM-1+ ICAM-1+ α-SMA+) corresponds to fibroblastic reticular cells that express various T-cell modulating cytokines, chemokines, and adhesion molecules. The second (CD90+ CD34+ CD105+ CD271+) represents a novel population of CD34+ SCs embedded in collagenous structures, such as the capsule and trabeculae, that predominantly produce extracellular matrix. We also demonstrated that these two SC subpopulations are distinct from two subsets of human LN pericytes, CD90+ CD146+ CD36+ NG2- pericytes in the walls of high endothelial venules and other small vessels, and CD90+ CD146+ NG2+ CD36- pericytes in the walls of larger vessels. Distinguishing between these CD90+ SC subpopulations in human LNs allows for further study of their respective impact on T-cell responses to tumor antigens and clinical outcomes.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Biomarcadores de Tumor / Células del Estroma / Pericitos / Ganglios Linfáticos / Melanoma Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cancer Immunol Res Año: 2020 Tipo del documento: Article País de afiliación: Nueva Zelanda

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Biomarcadores de Tumor / Células del Estroma / Pericitos / Ganglios Linfáticos / Melanoma Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cancer Immunol Res Año: 2020 Tipo del documento: Article País de afiliación: Nueva Zelanda